Company
United StatesPublic company, NASDAQ: RGENRepligen Corporation (NASDAQ: RGEN), Irving, TX – FDA Inspections
Inspection records and compliance data for Repligen Corporation in Irving, Texas. 5 FDA inspections on record, 2 Form 483s, last inspected February 08, 2024. Publicly traded as NASDAQ: RGEN.
Company Profile
This profile covers Repligen Corporation based in Irving, Texas, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 0
First inspected March 26, 2009. Last inspected February 8, 2024.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 8, 2024 | Not classified | Medical Devices & Rad Health | 1230139 |
| January 25, 2018 | Not classified | Medical Devices & Rad Health | 1041140 |
| November 4, 2013 | VAI | Medical Devices & Rad Health · Compliance: Devices | 853838 |
| August 7, 2013 | NAI | Medical Devices & Rad Health · Compliance: Devices | 843335 |
| March 26, 2009 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 572949 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Repligen Corporation
Stock ticker
RGEN
Exchange
NASDAQ
Share price
$168.39
Market cap
$10.8B
Price as of
November 6, 2026
FEI Number
1625657
Address
3400 Royalty Row, Irving, Texas 75062, United States
Country
United States
ID: 398de28a-0906-41a5-a0bf-d8e8cd6a60f6